×
About 1,832 results

ALLMedicine™ Hepatorenal Syndrome Center

Research & Reviews  871 results

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
https://doi.org/10.1056/NEJMoa2008290
The New England Journal of Medicine; Wong F, Pappas SC et. al.

Mar 3rd, 2021 - The vasoconstrictor terlipressin is used for type 1 hepatorenal syndrome (HRS-1) in many parts of the world and is part of the clinical practice guidelines in Europe. We conducted a phase 3 trial to confirm the efficacy and safety of terlipressin ...

"Living Donor Liver Transplant in patients with Hepatorenal syndrome without the use of...
https://doi.org/10.1111/ctr.14271
Clinical Transplantation; Singh SA, Prabhudesai AA et. al.

Feb 27th, 2021 - CRRT is often used to support the intra-operative course during liver transplantation ( LT) for patients with HRS. However, the use of intraoperative CRRT (IOCRRT) is not without its problems. Living donor liver transplantation (LDLT) is a planned...

Point-of-Care Echocardiography and Hemodynamic Monitoring in Cirrhosis and Acute-on-Chr...
https://doi.org/10.1177/0885066620988281
Journal of Intensive Care Medicine; Premkumar M, Kajal K et. al.

Jan 13th, 2021 - Point-of-Care (POC) transthoracic echocardiography (TTE) is transforming the management of patients with cirrhosis presenting with septic shock, acute kidney injury, hepatorenal syndrome and acute-on-chronic liver failure (ACLF) by correctly asses...

Does Anemia Have a Potential Effect on Type 2 Hepatorenal Syndrome?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762663
Canadian Journal of Gastroenterology & Hepatology; Bizid S, Yacoub H et. al.

Dec 31st, 2020 - Background/Aims. Hepatorenal syndrome (HRS) is a form of functional renal failure arising in advanced cirrhosis and is characterized by a poor survival rate. Anemia is frequently observed during the clinical course of cirrhosis. Our study aimed to...

Prevalence and short-term outcome of hepatorenal syndrome: A 9-year experience in a hig...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575105
PloS One; Rey R M, Delgado AF et. al.

Oct 20th, 2020 - Hepatorenal syndrome is a rare entity that is part of the complications of liver cirrhosis in its more severe stages. Without treatment, its mortality rate increases significantly. Terlipressin is considered to be the therapy of choice until the n...

see more →

Guidelines  1 results

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial p...
https://doi.org/10.1016/j.jhep.2010.05.004
Journal of Hepatology;

Jul 16th, 2010 - EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.|2010| ,|therapeutic use,diagnosis,etiology,therapy,diagnosis,etiology,therapy,therapeutic use,diagnosis,etiol...

see more →

Clinicaltrials.gov  907 results

Terlipressin Shows Benefit in Hepatorenal Syndrome but Risks Spark Concern
https://www.medscape.com/viewarticle/946833

Mar 3rd, 2021 - NEW YORK (Reuters Health) - Details of the phase-3 CONFIRM trial show the vasopressin analog terlipressin can reverse the effects of type 1 hepatorenal syndrome (HRS-1), although not without potentially serious side effects. The study, published i...

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
https://doi.org/10.1056/NEJMoa2008290
The New England Journal of Medicine; Wong F, Pappas SC et. al.

Mar 3rd, 2021 - The vasoconstrictor terlipressin is used for type 1 hepatorenal syndrome (HRS-1) in many parts of the world and is part of the clinical practice guidelines in Europe. We conducted a phase 3 trial to confirm the efficacy and safety of terlipressin ...

"Living Donor Liver Transplant in patients with Hepatorenal syndrome without the use of...
https://doi.org/10.1111/ctr.14271
Clinical Transplantation; Singh SA, Prabhudesai AA et. al.

Feb 27th, 2021 - CRRT is often used to support the intra-operative course during liver transplantation ( LT) for patients with HRS. However, the use of intraoperative CRRT (IOCRRT) is not without its problems. Living donor liver transplantation (LDLT) is a planned...

Point-of-Care Echocardiography and Hemodynamic Monitoring in Cirrhosis and Acute-on-Chr...
https://doi.org/10.1177/0885066620988281
Journal of Intensive Care Medicine; Premkumar M, Kajal K et. al.

Jan 13th, 2021 - Point-of-Care (POC) transthoracic echocardiography (TTE) is transforming the management of patients with cirrhosis presenting with septic shock, acute kidney injury, hepatorenal syndrome and acute-on-chronic liver failure (ACLF) by correctly asses...

Does Anemia Have a Potential Effect on Type 2 Hepatorenal Syndrome?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762663
Canadian Journal of Gastroenterology & Hepatology; Bizid S, Yacoub H et. al.

Dec 31st, 2020 - Background/Aims. Hepatorenal syndrome (HRS) is a form of functional renal failure arising in advanced cirrhosis and is characterized by a poor survival rate. Anemia is frequently observed during the clinical course of cirrhosis. Our study aimed to...

see more →

News  53 results

Terlipressin Shows Benefit in Hepatorenal Syndrome but Risks Spark Concern
https://www.medscape.com/viewarticle/946833

Mar 3rd, 2021 - NEW YORK (Reuters Health) - Details of the phase-3 CONFIRM trial show the vasopressin analog terlipressin can reverse the effects of type 1 hepatorenal syndrome (HRS-1), although not without potentially serious side effects. The study, published i...

Terlipressin Squeaks by FDA Review for Hepatorenal Syndrome 1
https://www.staging.medscape.com/viewarticle/934042

Jul 15th, 2020 - The US Food and Drug Administration's (FDA's) Cardiovascular and Renal Drugs Advisory Committee narrowly recommended, by an 8-7 vote, that the agency grant marketing approval to terlipressin for the treatment of hepatorenal syndrome type 1, a seve...

Terlipressin Squeaks by FDA Review for Hepatorenal Syndrome 1
https://www.medscape.com/viewarticle/934042

Jul 15th, 2020 - The US Food and Drug Administration's (FDA's) Cardiovascular and Renal Drugs Advisory Committee narrowly recommended, by an 8-7 vote, that the agency grant marketing approval to terlipressin for the treatment of hepatorenal syndrome type 1, a seve...

Alcoholism and Sudden Abdominal Distention in a 48-Year-Old
https://reference.medscape.com/viewarticle/724935_5

Jul 5th, 2020 - In this case, the patient's postprocedural course was characterized initially by worsening liver failure, elevated intra-abdominal pressures, and confusion. He eventually progressed to frank encephalopathy, hepatorenal syndrome, and pneumonia. Ult...

Terlipressin Shows Real-world Efficacy for Hepatorenal Syndrome
https://www.staging.medscape.com/viewarticle/932202

Jun 11th, 2020 - Takeaway Terlipressin is the most commonly prescribed vasoconstrictor for hospitalised patients with hepatorenal syndrome-acute kidney injury (HRS-AKI) in the UK, consistent with current guidelines. Initiation of terlipressin in patients with less...

see more →